Hence, in order to initially overview the dysfunction of SLC19A1 in different cancers, a transcriptomic analysis of SLC19A1 expression was performed on a pan-cancer scale, showing that SLC19A1 was expressed significantly higher in most of cancers analyzed, while an opposite expression was found in a few cancers. This evidence concerns the gene SLC19A1 and cancer.